Tradr 2X Short Innovation Daily ETF (SARK) Short Interest Ratio & Short Volume

Short interest is the volume of Tradr 2X Short Innovation Daily ETF shares that have been sold short but have not yet been covered or closed out. As of March 15th, investors have sold 164,600 shares of SARK short. 10.04% of Tradr 2X Short Innovation Daily ETF's shares are currently sold short. Learn More on Tradr 2X Short Innovation Daily ETF's current short interest.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Tradr 2X Short Innovation Daily ETF: Citadel Advisors LLC, Jane Street Group LLC, Susquehanna International Group LLP, and Belvedere Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 10.04% of Tradr 2X Short Innovation Daily ETF's floating shares are currently sold short.

Tradr 2X Short Innovation Daily ETF saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 164,600 shares, an increase of 36.0% from the previous total of 121,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

10.04% of Tradr 2X Short Innovation Daily ETF's shares are currently sold short. Here is how the short interest of companies compare to Tradr 2X Short Innovation Daily ETF: Global X Aging Population ETF (0.04%), Tema Cardiovascular and Metabolics ETF (0.02%), Tradr 2X Long Innovation ETF (13.50%), Global X Genomics & Biotechnology ETF (0.25%), Procure Space ETF (3.66%), Fidelity Disruptive Communications ETF (0.01%), Tema Oncology ETF (0.08%), Fidelity Disruptive Medicine ETF (0.00%), AOT Growth & Innovation ETF (0.04%), Invesco ESG NASDAQ 100 ETF (1.36%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks.

Short selling SARK is an investing strategy that aims to generate trading profit from Tradr 2X Short Innovation Daily ETF as its price is falling. SARK shares are trading up $8.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Tradr 2X Short Innovation Daily ETF occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SARK, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SARK, twice per month. The most recent reporting period available is March, 15 2025.